EP 3261658 B8 20190605 - DOSES AND METHODS OF ADMINISTERING TELAVANCIN
Title (en)
DOSES AND METHODS OF ADMINISTERING TELAVANCIN
Title (de)
DOSEN UND VERFAHREN ZUR VERABREICHUNG VON TELAVANCIN
Title (fr)
DOSES ET PROCÉDÉS D'ADMINISTRATION DE TÉLAVANCINE
Publication
Application
Priority
- US 201562119592 P 20150223
- US 2016018396 W 20160218
Abstract (en)
[origin: US2016243190A1] Doses and methods for administering telavancin or a pharmaceutically-acceptable salt thereof to a human patient having an infection caused by Staphylococcus aureus, such as bacteremia, pneumonia, endocarditis, osteomyelitis, a prosthetic joint infection or a complicated skin and skin structure infection, are disclosed. Also disclosed are methods for treating an infection caused by Staphylococcus aureus in a human patient using telavancin or a pharmaceutically-acceptable salt thereof. The dose of telavancin administered to the patient is determined, in part, by the weight and creatinine clearance of the patient.
IPC 8 full level
A61K 38/12 (2006.01); A61P 31/00 (2006.01)
CPC (source: CN EP KR US)
A61K 9/0019 (2013.01 - CN EP KR US); A61K 38/12 (2013.01 - CN KR US); A61K 38/14 (2013.01 - CN EP KR US); A61K 47/40 (2013.01 - CN EP KR US); A61P 7/00 (2017.12 - EP); A61P 9/00 (2017.12 - EP); A61P 11/00 (2017.12 - EP); A61P 19/00 (2017.12 - EP); A61P 19/02 (2017.12 - EP); A61P 19/08 (2017.12 - EP); A61P 29/00 (2017.12 - EP); A61P 31/00 (2017.12 - EP); A61P 31/04 (2017.12 - EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
US 2016243190 A1 20160825; AU 2016223090 A1 20170824; BR 112017017883 A2 20180717; CA 2976384 A1 20160901; CN 107257689 A 20171017; EA 201791895 A1 20180131; EP 3261658 A2 20180103; EP 3261658 B1 20190403; EP 3261658 B8 20190605; HK 1245644 B 20191206; IL 253791 A0 20170928; JP 2018505910 A 20180301; KR 20170123650 A 20171108; MX 2017010837 A 20171207; TN 2017000358 A1 20190116; TW 201639590 A 20161116; US 10751383 B2 20200825; US 2018236027 A1 20180823; WO 2016137806 A2 20160901; WO 2016137806 A3 20161020
DOCDB simple family (application)
US 201615046664 A 20160218; AU 2016223090 A 20160218; BR 112017017883 A 20160218; CA 2976384 A 20160218; CN 201680011698 A 20160218; EA 201791895 A 20160218; EP 16708853 A 20160218; HK 18105050 A 20180418; IL 25379117 A 20170802; JP 2017544316 A 20160218; KR 20177026865 A 20160218; MX 2017010837 A 20160218; TN 2017000358 A 20160218; TW 105105285 A 20160223; US 2016018396 W 20160218; US 201815945126 A 20180404